Predictors of Outcome in Idiopathic Rapidly Progressive Glomerulonephritis
Author Information
Author(s): Alexopoulos Efstathios, Gionanlis Lazaros, Papayianni Ekaterini, Kokolina Elizabeth, Leontsini Maria, Memmos Dimitrios
Primary Institution: Department of Nephrology, 'Hippokration' General Hospital, Thessaloniki, Greece
Hypothesis
The study aims to identify clinical, histological, and immunohistochemical parameters that predict outcomes in patients with idiopathic rapidly progressive glomerulonephritis.
Conclusion
Patients with ANCA-associated renal vasculitis respond better to treatment, and specific biomarkers can predict treatment response and long-term renal outcomes.
Supporting Evidence
- 24 out of 34 patients (70.6%) showed a complete or partial response to treatment.
- Serum CRP levels and the expression of specific biomarkers were significant predictors of treatment response.
- ANCA-positive patients had a better response rate compared to ANCA-negative patients.
Takeaway
This study looked at patients with a serious kidney disease and found that some tests can help doctors know who will get better with treatment.
Methodology
The study analyzed clinical and histological data from 34 adult patients with biopsy-proven focal necrotizing glomerulonephritis, assessing various parameters to predict treatment response.
Potential Biases
Potential biases may arise from the exclusion criteria and the single-center design of the study.
Limitations
The study's findings may be limited by the small sample size and the retrospective nature of the analysis.
Participant Demographics
The study included 34 adult patients (17 males and 17 females) with a mean age of 55.7 years.
Statistical Information
P-Value
p = 0.024
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website